CD44 and ovarian carcinoma: SHMT2 decreased, while SHMT2α increased stem cell like features of ovarian cancer cells, as identified by spheroid formation ability (Fig. 4C, D), expression of stemness markers CD44 and CD133 (Fig. 4E).